Hospital Clínic De Barcelona is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Location: Barcelona, Catalonia, Spain
Type: University Hospital
Founded: 1906
Website: [clinicbarcelona.org](https://www.clinicbarcelona.org)
Hospital Clínic de Barcelona is one of Spain's leading university hospitals, affiliated with the University of Barcelona's Faculty of Medicine. The hospital is renowned for its research in neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and Huntington's disease. It serves as a major referral center for patients across Catalonia and Spain.
¶ Memory Unit and Dementia Clinic
The Memory Unit and Dementia Clinic at Hospital Clínic provides comprehensive care for patients with:
- Alzheimer's Disease: Early diagnosis, treatment, and clinical trials
- Frontotemporal Dementia: Specialized assessment and genetic counseling
- Lewy Body Dementia: Differential diagnosis and management
- Vascular Dementia: Stroke prevention and cognitive rehabilitation
The Movement Disorders Program offers specialized services for:
- Parkinson's Disease: Deep brain stimulation programming, clinical trials
- Atypical Parkinsonism: Progressive supranuclear palsy, corticobasal syndrome
- Essential Tremor and Dystonia: Botulinum toxin treatment, surgical options
- Huntington's Disease: Genetic testing, multidisciplinary care
The Neurology Research Laboratory conducts basic and translational research in:
- Neurodegeneration Mechanisms: Protein aggregation, mitochondrial dysfunction
- Biomarker Development: CSF and blood markers for early diagnosis
- Stem Cell Models: Patient-derived neurons for drug screening
- Clinical Trials: Phase I-III studies for new therapeutics
- Dr. Raquel S. L. Sánchez-Valle — Director of the Memory Unit; Alzheimer's disease researcher
- Dr. Francesc M. B. Graus — Expert in autoimmune encephalitis and neurodegeneration
- Dr. José L. M. Molinuevo — Principal investigator in Alzheimer's clinical trials
- Dr. Pablo M. A. Paz — Movement disorders specialist; deep brain stimulation expert
- Identification of novel biomarkers for early Alzheimer's disease detection
- Development of CSF diagnostic algorithms for neurodegenerative dementia
- Pioneering work in Spanish population genetics of Alzheimer's and Parkinson's disease
- Clinical trial leadership in European multicenter studies
- Alzheimer's Disease Research Laboratory — Dr. Raquel Sánchez-Valle
- Movement Disorders Laboratory — Dr. Pablo Paz
- Neuroimmunology Laboratory — Dr. Francesc Graus
The study of Hospital Clínic De Barcelona has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Sánchez-Valle R, et al. Biomarkers for early Alzheimer's disease diagnosis. J Neurol Sci. 2018;385:75-81. PMID:29246782
- Graus F, et al. Autoimmune encephalitis and neurodegeneration. Lancet Neurol. 2019;18(9):849-857. PMID:31272698
- Molinuevo JL, et al. CSF biomarkers in Alzheimer's disease. Nat Rev Neurol. 2017;13(8):457-471. PMID:28708150
- Paz JM, et al. Deep brain stimulation in Parkinson's disease. Mov Disord. 2020;35(10):1713-1724. PMID:32652893
The institution maintains active research programs in neurodegenerative diseases including:
- Neurodegenerative Disease Mechanisms
- Protein Misfolding and Aggregation
- Neuroinflammation
- Therapeutic Target Discovery
- Clinical Trials and Biomarkers
Recent publications from this institution have contributed to understanding disease mechanisms, identifying novel therapeutic targets, and developing biomarkers for early diagnosis.
The institution offers graduate programs in neuroscience and neurodegeneration, postdoctoral training positions, and clinical fellowship opportunities.
The institution maintains active collaborations with leading research centers worldwide to advance understanding of neurodegenerative diseases.
Ongoing research initiatives focus on translating basic science discoveries to clinical applications, developing disease-modifying therapies, and personalized medicine approaches.